Dhote V - Search Results

1

Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia-reperfusion injury in rats.

Dhote V, Balaraman R. Dhote V, et al. Clin Exp Pharmacol Physiol. 2008 May;35(5-6):630-7. doi: 10.1111/j.1440-1681.2008.04845.x. Epub 2008 Mar 3. Clin Exp Pharmacol Physiol. 2008. PMID: 18318745

2

Gender specific effect of progesterone on myocardial ischemia/reperfusion injury in rats.

Dhote VV, Balaraman R. Dhote VV, et al. Life Sci. 2007 Jun 27;81(3):188-97. doi: 10.1016/j.lfs.2007.05.010. Epub 2007 May 24. Life Sci. 2007. PMID: 17585947

3

Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats.

Dhote V, Joharapurkar A, Kshirsagar S, Dhanesha N, Patel V, Patel A, Raval S, Jain M. Dhote V, et al. Clin Exp Pharmacol Physiol. 2011 May;38(5):338-44. doi: 10.1111/j.1440-1681.2011.05513.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21401695

4

Noscapine alleviates cerebral damage in ischemia-reperfusion injury in rats.

Kawadkar M, Mandloi AS, Saxena V, Tamadaddi C, Sahi C, Dhote VV. Kawadkar M, et al. Among authors: dhote vv. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):669-683. doi: 10.1007/s00210-020-02005-x. Epub 2020 Oct 27. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 33106921

5

Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.

Dhanesha N, Joharapurkar A, Shah G, Kshirsagar S, Dhote V, Sharma A, Jain M. Dhanesha N, et al. Among authors: dhote v. Clin Exp Pharmacol Physiol. 2012 Jan;39(1):69-77. doi: 10.1111/j.1440-1681.2011.05640.x. Clin Exp Pharmacol Physiol. 2012. PMID: 22060140

6

Combination therapy for cerebral ischemia: do progesterone and noscapine provide better neuroprotection than either alone in the treatment?

Kawadkar M, Mandloi AS, Singh N, Mukharjee R, Dhote VV. Kawadkar M, et al. Among authors: dhote vv. Naunyn Schmiedebergs Arch Pharmacol. 2022 Feb;395(2):167-185. doi: 10.1007/s00210-021-02187-y. Epub 2022 Jan 6. Naunyn Schmiedebergs Arch Pharmacol. 2022. Retraction in: Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar;397(3):1917. doi: 10.1007/s00210-024-02995-y PMID: 34988596 Retracted.

7

Neuroprotective effects of combined trimetazidine and progesterone on cerebral reperfusion injury.

Dhote V, Mandloi AS, Singour PK, Kawadkar M, Ganeshpurkar A, Jadhav MP. Dhote V, et al. Curr Res Pharmacol Drug Discov. 2022 May 6;3:100108. doi: 10.1016/j.crphar.2022.100108. eCollection 2022. Curr Res Pharmacol Drug Discov. 2022. PMID: 35602337 Free PMC article.

8

Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.

Dhanesha N, Joharapurkar A, Shah G, Dhote V, Kshirsagar S, Bahekar R, Jain M. Dhanesha N, et al. Among authors: dhote v. J Diabetes. 2012 Dec;4(4):369-77. doi: 10.1111/j.1753-0407.2012.00193.x. J Diabetes. 2012. PMID: 22356440

9

Selective thyromimetics using receptor and tissue selectivity approaches: prospects for dyslipidemia.

Joharapurkar AA, Dhote VV, Jain MR. Joharapurkar AA, et al. Among authors: dhote vv. J Med Chem. 2012 Jun 28;55(12):5649-75. doi: 10.1021/jm2004706. Epub 2012 May 1. J Med Chem. 2012. PMID: 22512468 Review. No abstract available.

10

Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect.

Dhanesha N, Joharapurkar A, Shah G, Dhote V, Kshirsagar S, Bahekar R, Jain M. Dhanesha N, et al. Among authors: dhote v. Pharmacol Rep. 2012;64(1):140-9. doi: 10.1016/s1734-1140(12)70740-5. Pharmacol Rep. 2012. PMID: 22580530 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters